Back

Role of SCAL1 in Modulating Oxidative Stress, Cancer Stemness, Apoptotic Resistance in Tumorigenic Differentiation of Cigarette Smoke-Exposed BEAS-2B Cells

Sengupta, D.; Banerjee, S.; Sengupta, M.

2024-08-07 cancer biology
10.1101/2024.08.05.606632 bioRxiv
Show abstract

The smoke and cancer-associated lncRNA 1 (SCAL1) is an emergent biomarker in lung cancer. However, the precise role of SCAL1 as a mediator of tobacco smoke-induced lung carcinogenesis remains unclear. BEAS-2B cells were cultured and exposed to 20% cigarette smoke extract (CSE), followed by quantification of SCAL1. We evaluated the impact of SCAL1 on cell viability, ROS mitigation, cancer stemness, tumorigenic differentiation, cellular invasiveness, and apoptosis for different CSE incubation time points through SCAL1 expressional modulation using SCAL1-specific siRNAs and scrambled controls. We observed an upregulation of SCAL1 in cells exposed to CSE for 2, 4, and 6 hours, with the highest expression observed at 6 hours (p<0.001). Exposure of BEAS-2B cells to CSE showed the formation of focal adhesions and stress fibers resembling tunneling nanotubes. Intracellular ROS levels significantly increased upon CSE exposure compared to control cells (p<0.05). We found increased levels of anti-apoptotic and cancer stem (CSC) cell markers like BCL2, ALDH1A1, CD133, CD44, and TCTP and decreased levels of TP53 in CSE-exposed cells. Knockdown of SCAL1 using siRNA transfection reversed these effects at all time points. Additionally, we observed a significant decrease in the number of spheroid colonies in siSCAL1 (+) cells compared to siSCAL1 (-) cells (p<0.01) exposed to CSE. SCAL1 is pivotal in mediating cellular responses to cigarette smoke, leading to tumorigenic differentiation of BEAS-2B cells. Understanding the mechanisms could provide valuable insights into lung cancer pathogenesis and therapeutic approaches.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3102 papers in training set
Top 3%
12.7%
2
PLOS ONE
4510 papers in training set
Top 17%
10.4%
3
Oncotarget
15 papers in training set
Top 0.1%
6.5%
4
International Journal of Molecular Sciences
453 papers in training set
Top 1%
5.0%
5
Cancers
200 papers in training set
Top 1%
3.7%
6
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 2%
2.7%
7
Redox Biology
64 papers in training set
Top 0.3%
2.4%
8
Environmental Research
46 papers in training set
Top 0.6%
2.1%
9
Archives of Toxicology
14 papers in training set
Top 0.1%
2.1%
10
Toxicological Sciences
38 papers in training set
Top 0.2%
2.1%
11
Journal of Translational Medicine
46 papers in training set
Top 0.6%
1.9%
50% of probability mass above
12
PeerJ
261 papers in training set
Top 7%
1.7%
13
Epigenetics
43 papers in training set
Top 0.4%
1.7%
14
Frontiers in Molecular Biosciences
100 papers in training set
Top 2%
1.4%
15
Frontiers in Oncology
95 papers in training set
Top 2%
1.4%
16
eLife
5422 papers in training set
Top 46%
1.4%
17
Biomolecules
95 papers in training set
Top 0.9%
1.3%
18
Biomedicines
66 papers in training set
Top 2%
1.1%
19
Toxicology and Applied Pharmacology
13 papers in training set
Top 0.2%
1.0%
20
Respiratory Research
19 papers in training set
Top 0.4%
0.9%
21
Life Sciences
25 papers in training set
Top 1%
0.9%
22
Molecular Oncology
50 papers in training set
Top 0.8%
0.8%
23
Cells
232 papers in training set
Top 5%
0.8%
24
ERJ Open Research
44 papers in training set
Top 0.7%
0.8%
25
American Journal of Physiology-Lung Cellular and Molecular Physiology
39 papers in training set
Top 0.4%
0.8%
26
Heliyon
146 papers in training set
Top 5%
0.8%
27
Biochemistry and Biophysics Reports
28 papers in training set
Top 1%
0.8%
28
Free Radical Biology and Medicine
33 papers in training set
Top 0.4%
0.8%
29
Cancer Research Communications
46 papers in training set
Top 1%
0.8%
30
Journal of the Endocrine Society
11 papers in training set
Top 0.4%
0.7%